Back to PathoKing

Parkinson’s module

Parkinson’s Disease

Understand Parkinson’s disease as progressive nigrostriatal dopamine loss that alters basal ganglia circuit output, producing bradykinesia, rigidity, tremor and wide-ranging non-motor dysfunction.

intermediate40 min

Clinically reviewed by Mark · NMC-registered nurse

Aetiology

What contributes to Parkinson’s disease?

Most disease is sporadic, with interacting age, genetic and environmental influences.

Age-related vulnerability

Typical setting: Incidence rises substantially with age.

Declining mitochondrial, proteostatic and repair capacity reduces neuronal resilience, although Parkinson’s is not an inevitable part of ageing.

Genetic susceptibility

Typical setting: Family history or younger-onset disease may suggest variants such as LRRK2, GBA, PRKN or PINK1.

Different genes affect lysosomes, mitochondria, kinase signalling or synaptic protein handling and produce heterogeneous risk and phenotypes.

Environmental toxicant exposure

Typical setting: Some pesticide or solvent exposures are associated epidemiologically.

Mitochondrial or oxidative injury may increase risk, but exposure history rarely proves the cause in one person.

Repeated head injury

Typical setting: Cumulative traumatic exposure.

Neuroinflammation and protein-handling disruption may increase later parkinsonism risk, while single minor injuries are not determinative.

Secondary or drug-induced parkinsonism

Typical setting: Dopamine-blocking medicines, vascular disease or structural disorders.

Parkinsonian signs can result without idiopathic nigral Lewy disease, making medication review and pattern recognition essential.

Mechanism chain

Mechanism chain

Nigral neuron loss shifts basal ganglia output towards excessive movement suppression.

1

Protein and cellular stress accumulate

Alpha-synuclein misfolding, impaired lysosomal clearance, mitochondrial dysfunction and inflammation interact in vulnerable neurons.

2

Nigral dopaminergic neurons degenerate

Substantia nigra pars compacta cell loss progressively reduces dopamine delivery to the dorsal striatum.

Checking account access...